"Triazines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES.
| Descriptor ID |
D014227
|
| MeSH Number(s) |
D03.383.931
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Triazines".
Below are MeSH descriptors whose meaning is more specific than "Triazines".
This graph shows the total number of publications written about "Triazines" by people in this website by year, and whether "Triazines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Triazines" by people in Profiles.
-
Asadi-Pooya AA, Farazdaghi M. Rational therapy with lamotrigine or levetiracetam: Which one to select? J Clin Neurosci. 2022 May; 99:49-52.
-
Ludwig S, Hong CS, Razzo BM, Fabian KPL, Chelvanambi M, Lang S, Storkus WJ, Whiteside TL. Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma. Cancer Immunol Immunother. 2019 Jul; 68(7):1133-1141.
-
Kwako LE, Spagnolo PA, Schwandt ML, Thorsell A, George DT, Momenan R, Rio DE, Huestis M, Anizan S, Concheiro M, Sinha R, Heilig M. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study. Neuropsychopharmacology. 2015 Mar 13; 40(5):1053-63.
-
Deeb S, McKeown DA, Torrance HJ, Wylie FM, Logan BK, Scott KS. Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases. J Anal Toxicol. 2014 Oct; 38(8):485-94.
-
Chang RS, Cole AJ. Lamotrigine-induced lupus-like syndrome: a case report and literature review. Am J Ther. 2014 May-Jun; 21(3):e85-7.
-
Kelley RK. Brivanib and FOLFOX in hepatocellular carcinoma: finding the common themes among negative trials. J Clin Oncol. 2013 Oct 01; 31(28):3483-6.
-
Farooque P, Goraya J, Valencia I, Carvalho KS, Hardison HH, Legido A, Khurana DS. Early-onset childhood absence epilepsy: is it a distinct entity? Epileptic Disord. 2011 Dec; 13(4):411-6.
-
Bhagwat SV, Gokhale PC, Crew AP, Cooke A, Yao Y, Mantis C, Kahler J, Workman J, Bittner M, Dudkin L, Epstein DM, Gibson NW, Wild R, Arnold LD, Houghton PJ, Pachter JA. Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin. Mol Cancer Ther. 2011 Aug; 10(8):1394-406.
-
Aye T, Mehrvar M, Anderson WA. Effects of photocatalysis on the biodegradability of Cibacron Brilliant Yellow 3G-P (reactive yellow 2). J Environ Sci Health A Tox Hazard Subst Environ Eng. 2004; 39(1):113-26.
-
Aye T, Anderson WA, Mehrvar M. Photocatalytic treatment of cibacron brilliant yellow 3G-P (reactive yellow 2 textile dye). J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003 Sep; 38(9):1903-14.